• Explore /
  • Poster
  • / Biomarker validation study: Genes involved in ubiquitin proteasome system (UPS) dependent EGFR-degradation for prediction of efficacy in metastatic colorectal cancer patients treated with cetuximab.

Biomarker validation study: Genes involved in ubiquitin proteasome system (UPS) dependent EGFR-degradation for prediction of efficacy in metastatic colorectal cancer patients treated with cetuximab.

Abstract Poster

Authors

Sebastian Stintzing

Sebastian Stintzing

USC Norris Comprehensive Cancer Center, Los Angeles, CA

Sebastian Stintzing , Stefan Stremitzer , Volker Heinemann , Alfredo Falcone , Fotios Loupakis , Chiara Cremolini , Carlotta Antoniotti , Yu Sunakawa , Satoshi Matsusaka , Shinichi Yamauchi , Wu Zhang , Dongyun Yang , Yan Ning , Ana Sebio , Diana L. Hanna , Saadat Siamak , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3571)

DOI

10.1200/jco.2014.32.15_suppl.3571

Abstract #

3571

Poster Bd #

34

Abstract Disclosures

Similar Posters

First Author: Sebastian Stintzing

First Author: Madiha Naseem

First Author: Francesca Battaglin

First Author: Madiha Naseem